Quevedo, Rene
Spreafico, Anna
Bruce, Jeff
Danesh, Arnavaz
El Ghamrasni, Samah
Giesler, Amanda
Hanna, Youstina
Have, Cherry
Li, Tiantian
Yang, S. Y. Cindy
Zhang, Tong
Asa, Sylvia L.
Haibe-Kains, Benjamin
Krzyzanowska, Monika
Smith, Adam C.
Singh, Simron
Siu, Lillian L.
Pugh, Trevor J.
Funding for this research was provided by:
Cancer Research Society and the Carcinoid NeuroEndocrine Tumour Society Canada (#19341)
Canada Foundation for Innovation (CFI 340 #32383)
Article History
Received: 28 August 2019
Accepted: 10 March 2020
First Online: 28 April 2020
Ethics approval and consent to participate
: The University Health Network Research Ethics Board (UHN REB) approved this study (protocol number 13-6061-C) that includes obtaining informed consent from participants to collect, store, use, and share biological samples and data for the study. The UHN REB operates in compliance with the Tri-Council Policy Statement, ICH Guideline for Good Clinical Practice E6(R1), Ontario Personal Health Information Protection Act (2004), Part C Division 5 of the Food and Drug Regulations, and Part 4 of the Natural Health Products Regulations and the Medical Devices Regulations of Health Canada. This research conformed to the Declaration of Helsinki.
: Participants consented to sharing of de-identified data, having their name, address, and telephone stripped from any reports, publications, or presentations originating from this study. All participant information was anonymized.
: The authors declare that they have no competing interests.